Marzia Monica Giuliani Selected Research

4CMenB vaccine

1/2020	Culture-Confirmed Invasive Meningococcal Disease in Canada, 2010 to 2014: Characterization of Serogroup B Neisseria meningitidis Strains and Their Predicted Coverage by the 4CMenB Vaccine.
10/2013	Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage.
2/2013	Transcriptional regulation of the nadA gene in Neisseria meningitidis impacts the prediction of coverage of a multicomponent meningococcal serogroup B vaccine.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marzia Monica Giuliani Research Topics

Disease

5	Meningococcal Infections 01/2021 - 06/2002
2	Infections 01/2019 - 02/2013
2	Meningitis 07/2011 - 06/2002
1	Streptococcal Infections (Streptococcal Infection) 01/2019
1	Communicable Diseases (Infectious Diseases) 02/2013
1	Inflammation (Inflammations) 02/2013
1	Sepsis (Septicemia) 06/2002

Drug/Important Bio-Agent (IBA)

6	VaccinesIBA 01/2021 - 06/2002
4	AntigensIBA 01/2021 - 06/2002
3	4CMenB vaccineIBA 01/2020 - 02/2013
2	AntibodiesIBA 02/2013 - 06/2002
1	EpitopesIBA 01/2019
1	Biotin (Vitamin H)FDA Link 01/2019
1	Immunoglobulin G (IgG)IBA 01/2019
1	Polysaccharides (Glycans)IBA 01/2019
1	AcidsIBA 02/2013
1	Carrier Proteins (Binding Protein)IBA 07/2011
1	Complement Factor H (Factor H)IBA 07/2011
1	Anti-Bacterial Agents (Antibiotics)IBA 06/2002
1	Proteins (Proteins, Gene)FDA Link 06/2002

Therapy/Procedure

1	Antibiotic Prophylaxis 01/2019
1	Therapeutics 06/2002